Related by context. All words. (Click for frequent words.) 60 NEVO 60 TAXUS stent 60 dipyridamole plus 59 XIENCE V Everolimus Eluting 59 XIENCE V stent 59 TAXUS Stent 59 functional mitral regurgitation 59 everolimus eluting stents 58 pain palliation 58 paclitaxel eluting stent 58 Eluting Coronary Stent System 58 XIENCE TM 58 Edwards SAPIEN XT 57 drug eluting stent DES 57 carotid artery stenting 57 COR Analyzer 57 drug eluting coronary stent 57 TAXUS Express Stent 57 carotid endarterectomy CEA 57 MitraClip 57 Sirolimus eluting Coronary Stent 57 sirolimus eluting stents 57 multicenter prospective 57 NAVISTAR R 57 Ascendra 57 Fully Covered Stent 57 carotid artery stenting CAS 56 everolimus eluting stent 56 demonstrated clinically meaningful 56 STRIDE PD 56 percutaneous vertebroplasty 56 TAXUS Liberte 56 CYPHER Stent 56 briakinumab 56 TAXUS VI 56 TAXUS Liberte Stent 56 bioprosthetic valve 56 sirolimus eluting 56 stent DES 56 non valvular atrial 56 Everolimus Eluting Coronary Stent 56 hsCRP levels 56 zotarolimus 56 TAXUS Express2 Paclitaxel Eluting 56 ADCS CGIC 56 ABSORB trial 55 symptomatic VTE 55 MoxDuo TM IR 55 NEVO TM 55 V Everolimus Eluting Coronary 55 Cypher Stent 55 certolizumab 55 morphometric vertebral fractures 55 Endeavor DES 55 paclitaxel eluting stents 55 multicenter randomized controlled 55 Percutaneous Coronary Intervention 55 antiarrhythmic drug 55 CYPHER R Sirolimus eluting 55 PCI percutaneous coronary 55 oncologic outcomes 55 AF ablation 55 TAXUS TM 55 Pegylated Liposomal Doxorubicin 55 ACTEMRA TM 55 CYPHER ® Stent 54 PROMUS TM 54 graft patency 54 novel oral anticoagulant 54 Atom Stent 54 Nitinol Stent 54 primary percutaneous coronary 54 reteplase 54 prospectively stratified 54 Endeavor drug eluting 54 paclitaxel eluting coronary stent 54 serum phosphorous 54 Platinum Chromium 54 GORE VIABAHN Endoprosthesis 54 Drug eluting stent 54 Carotid Revascularization Endarterectomy vs. 54 Echocardiographic 54 Acute Myocardial Infarction AMI 54 TAXUS Liberte Long 54 BENICAR HCT 54 HuMax EGFr 54 Ophena 54 efficacy endpoint 54 CTO recanalization 54 Oral NKTR 54 StarClose 54 Angiographic 54 UA NSTEMI 54 renal artery stenting 54 Paclitaxel Eluting Coronary Stent 54 Acute Myocardial Infarction 54 thrombus aspiration 54 sargramostim 54 THERMOCOOL R 54 RE LY 54 Self Expanding Stent 54 Custom NX R 54 ULORIC 54 analgesic efficacy 54 dual endothelin receptor antagonist 54 VESTAsync 54 Vascular Wrap 53 cerebral somatic oximeter 53 sipuleucel T 53 TAXUS R 53 Edge STudy 53 transesophageal echocardiography TEE 53 abluminal 53 PRECISE 53 VELCADE melphalan 53 ATACAND 53 periprocedural 53 Coronary Stent 53 primary patency 53 Randomized Evaluation 53 prospective multicenter study 53 fibrinolytic therapy 53 Novacor R 53 TM Everolimus Eluting 53 elective PCI 53 antithrombotic therapy 53 TAXUS Liberte stent 53 Coronary Artery Bypass Graft 53 AIR2 Trial 53 TAXUS Express2 53 OMS# 53 mechanical thrombectomy 53 OZURDEX 53 pioglitazone HCl 53 MERLIN TIMI 53 Vascugel ® 53 undergoing percutaneous coronary 53 zotarolimus eluting stent 53 DAPT 53 Liberte TM 53 venous thromboembolic disease 53 Endovascular System 53 multivessel disease 53 Xience V 53 phase IIIb 53 Randomized controlled 53 patients undergoing CABG 53 bioabsorbable stent 53 EnRhythm MRI SureScan pacing 53 carotid stenting 53 Anticoagulation 53 bi ventricular pacing 53 transdermal estradiol 52 ARIXTRA 52 HDL Selective Delipidation 52 Skin sterol 52 dose atorvastatin 52 Cardiorespiratory fitness 52 transcranial Doppler ultrasound 52 clinically meaningful improvements 52 undergoing coronary artery 52 pharmacokinetic PK 52 transcatheter 52 DES implantation 52 pharmacodynamics PD 52 cardiac resynchronisation therapy 52 BRIM2 52 Emboli Capture Guidewire 52 balloon kyphoplasty 52 reperfusion therapy 52 Betaferon R 52 PROMUS 52 PROMUS ® 52 EDARBI 52 olanzapine LAI 52 CARE HF 52 EQUETRO 52 NSTE ACS 52 weekly subcutaneous injections 52 bifurcation lesions 52 SYNTAX trial 52 undetectable HBV DNA 52 MYTHOS trial 52 IABP 52 transurethral 52 ACCULINK 52 Medtronic CoreValve 52 Bare Metal Stent 52 Anti Bacterial Envelope 52 hemostatic efficacy 52 Embolic Protection System 52 relapsing multiple sclerosis 52 resynchronization therapy 52 CD HORIZON 52 ABVD 52 Prospective Randomized 52 BoNTA 52 Carotid endarterectomy 52 Emboshield 52 secondary efficacy endpoint 52 stenoses 52 HSCT 52 epoetin alpha 52 desvenlafaxine succinate 52 aldosterone antagonist 52 reduce serum phosphate 52 CaPSURE 52 SUPERA stent 52 ostial 52 ZYBRESTAT fosbretabulin 52 angiographic outcomes 52 PCWP 52 tirofiban 52 HORIZONS AMI trial 52 Q#IR 52 Teriflunomide 52 AVONEX PEN 52 Tasigna prolongs 52 percutaneous intervention 52 Edwards SAPIEN valve 52 EmbraceAC 52 inotropic therapy 52 elective percutaneous coronary 51 multicentre randomized 51 unstable angina UA 51 clevidipine 51 Pharmacokinetic parameters 51 PTNS 51 myocardial viability 51 MEND CABG 51 saphenous vein graft 51 thromboembolic complications 51 sirolimus eluting stent 51 liposomal doxorubicin 51 Cardiac Resynchronization Therapy 51 Export Aspiration Catheter 51 Dr. Kandzari 51 Dabigatran etexilate 51 Accelerated Partial Breast Irradiation 51 dose dexamethasone 51 iodixanol 51 carotid stents 51 hematological parameters 51 PROMUS Element 51 STARFlex R 51 anthracycline therapy 51 PASI scores 51 BEXXAR Therapeutic Regimen 51 intravenous bolus 51 CA9 SCAN 51 octreotide 51 coronary intervention 51 XIENCE 51 carotid angioplasty 51 PFO migraine 51 divalproex sodium 51 Doxil ® 51 TAXUS ® 51 percutaneous transluminal coronary angioplasty 51 Pemetrexed 51 iliac artery disease 51 bioabsorbable polymer 51 ARCOXIA 51 nonmetastatic prostate cancer 51 intraobserver 51 PROMUS R 51 retrospective cohort 51 gemtuzumab ozogamicin 51 Sirolimus eluting 51 strontium ranelate 51 TAXUS Express Atom Stent 51 USpella 51 TAXUS Liberté 51 EXJADE 51 CYPHER R 51 thoracoscopic lobectomy 51 ExAblate R 51 CTEPH 51 icatibant 51 paclitaxel eluting 51 ORTHO EVRA R 51 endoluminal 51 Primary endpoints 51 LNG IUS 51 TAXUS Express 51 Medtronic Endeavor 51 postprocedure 51 drug eluting stent implantation 51 pharmacokinetics PK 51 Intravitreal 51 methotrexate monotherapy 51 irbesartan 51 Resolute DES 50 urodynamic 50 beta blocker therapy 50 conventional coronary angiography 50 MADIT II 50 concurrent chemoradiation 50 urinary N telopeptide 50 Endeavor stent 50 rt PA 50 colorectal liver metastases 50 adenoma recurrence 50 antiarrhythmic drugs 50 LMWH 50 endovascular repair 50 EURIDIS 50 inhaled budesonide 50 TEVAR 50 Stent Thrombosis 50 patients undergoing percutaneous 50 Thrombolysis 50 platelet inhibitor 50 Percutaneous Coronary Interventions 50 endothelin antagonists 50 Carotid 50 Tarceva TM 50 XIENCE PRIME TM 50 CYPHER R Stent 50 Acute Ischemic Stroke 50 underwent percutaneous coronary 50 cobalt chromium stent 50 Multicenter Automatic Defibrillator Implantation 50 Multicenter 50 enthesitis 50 DUROS 50 interobserver 50 SIMPADICO 50 BioMatrix 50 doxorubicin docetaxel 50 TAXUS IV 50 Fibromyalgia Impact Questionnaire 50 Heparin Bioactive Surface 50 bivalirudin monotherapy 50 anticoagulant therapy 50 electrophysiologic 50 Endoprosthesis 50 Valdoxan 50 quantitative coronary angiography 50 MGuard ™ 50 Long Term Efficacy 50 nonrandomized 50 AneuRx 50 preoperative intraoperative 50 antithrombotic 50 eNO 50 prospective multicenter randomized 50 Montgomery Åsberg Depression 50 FinESS 50 Perforomist Inhalation Solution 50 binary restenosis 50 TUMT 50 dual antiplatelet therapy 50 Cypher Sirolimus 50 warfarin sodium 50 AngioJet 50 Phase 2b kidney transplant 50 XL# SAR# 50 hematologic parameters 50 autologous cultured chondrocytes 50 biologic DMARD 50 RRMS patients 50 haematologic 50 CALGB # [002] 50 biventricular pacing 50 Focalin XR 50 Microwave Ablation System 50 nCPAP 50 relapsed myeloma 50 mg kg BID 50 prucalopride 50 alteplase 50 mitoxantrone plus 49 prospectively evaluated 49 drug eluting stent 49 underwent coronary angiography 49 Restenosis 49 STENT 49 Serum creatinine 49 #beta estradiol 49 pimecrolimus 49 Xience Prime 49 Percutaneous Transluminal Coronary Angioplasty 49 postintervention 49 empirically validated 49 FFR measurements 49 postmenopausal osteoporotic women 49 Vertos II 49 acute STEMI 49 Endeavor Drug Eluting 49 GP IIb IIIa inhibitors 49 SYNTAX 49 mycophenolate mofetil 49 PERSEUS 49 AGILECT R 49 COPERNICUS 49 chemoradiation therapy 49 octreotide LAR 49 ZOLINZA 49 CUSTOM III 49 ivabradine 49 thromboembolic 49 multicenter randomized 49 revascularization procedure 49 Ascendra transapical delivery 49 WallFlex Biliary RX 49 mycophenolate mofetil MMF 49 venlafaxine XR 49 intermittent dosing 49 AVERROES 49 intra arterial 49 ASTEROID 49 GP IIb IIIa inhibitor 49 Ziprasidone 49 AVANDIA 49 posttreatment 49 elevated ALT 49 ACCORD Lipid 49 postoperative mortality 49 TAXUS Element 49 Resurgex Plus 49 Stretta procedure 49 randomized blinded 49 TriRima 49 BPH LUTS 49 prospective randomized controlled 49 BARI 2D 49 laser Doppler 49 dabigatran etexilate 49 Brief Psychiatric 49 cystoscopic 49 Ceplene/IL-2 49 revascularized 49 thrombolytic therapy 49 Eluting Stent 49 preintervention 49 DAS# CRP 49 Dementia Related Psychosis 49 NexStent 49 perioperatively 49 Stenting Trial CREST 49 NMES 49 ® pioglitazone HCl 49 levetiracetam 49 CANCIDAS 49 achieved statistical significance 49 pamidronate 49 randomized controlled multicenter 49 Acute Coronary Syndromes ACS 49 Secondary endpoints included 49 ROCKET AF 49 Taxus Liberte stent 49 clopidogrel Plavix 49 methacholine challenge 49 prospective multicentre 49 GORE TAG 49 ImmuKnow assay 49 ARB telmisartan 49 TAXUS Element Stent 49 sitaxsentan 49 dose escalation phase 49 formoterol fumarate 49 EQ 5D 49 CYPHER stent 49 florbetaben 49 Secondary endpoints 49 convergent validity 49 Genous 49 PROTECT II 49 metastatic malignant 49 Axxion TM 49 noninferior 49 NSTEMI 49 bioresorbable polymer 49 RECIST Response Evaluation Criteria 49 CLARITY study 49 dopamine partial agonist 49 Bivalirudin 49 TM Drug Eluting 49 carotid stent 49 Spiriva Handihaler 49 cediranib 49 noninferiority 49 pharmacologic stress 49 Signal X6 49 left ventricular dysfunction 49 thrombotic complications 49 GENASIS 49 CONTRAINDICATIONS 49 Stenting 48 IFN alfa 48 fondaparinux 48 Paliperidone ER 48 CAPRA 48 Ranolazine 48 patency 48 urate lowering 48 anticoagulation 48 thrombolytics 48 PFO closure 48 COPAXONE R 48 ENDEAVOR III 48 cangrelor 48 ICD Registry 48 ranolazine 48 pegylated alpha interferon 48 mid urethral sling 48 dobutamine 48 randomized discontinuation 48 pharmacokinetic pharmacodynamic 48 HepaSphere 48 dronedarone 48 Prosaptide 48 TASKi3 48 VTE prophylaxis 48 olmesartan 48 Rivaroxaban 48 Subgroup analyzes 48 Augment Injectable 48 prospective nonrandomized 48 Platinol ® 48 intradermal injections 48 aripiprazole Abilify 48 Ejection Fraction 48 microbiologically evaluable 48 ASCEND HF 48 GEM OS2 48 Meta analyzes 48 MULTI LINK 48 TAXUS 48 sirolimus 48 Carotid Artery Stenting 48 eszopiclone 48 PARTNER Trial 48 Stent Graft 48 LVAS 48 CORD II 48 HF ACTION 48 Afatinib 48 gadobutrol 48 serotonin norepinephrine reuptake inhibitor 48 Psoriasis Area 48 multidose 48 MGN# 48 Telmisartan 48 stents BMS 48 VerifyNow P#Y# 48 ibandronate 48 ICD implantation 48 donepezil Aricept 48 Temsirolimus 48 tolerability profiles 48 GRAVITAS trial 48 Resolute stent 48 STEMI patients 48 glycoprotein IIb IIIa inhibitor 48 naproxen esomeprazole magnesium 48 Kaplan Meier analysis 48 intratympanic 48 RE MODEL 48 thetreatment 48 pharmacodynamic properties 48 Index CDAI 48 retest reliability 48 deferoxamine 48 OVATIO 48 interobserver agreement 48 CYPHER SELECT TM 48 intertrochanteric fractures 48 antiplatelet agent 48 Drug Eluting Stent System 48 VADT 48 prospective randomized multicenter 48 TAVR 48 prospectively enrolled 48 tocilizumab 48 sternal wound infections 48 stent restenosis 48 LIALDA 48 STARFlex 48 TWYNSTA 48 paliperidone ER 48 CYPHER ® 48 stent BMS 48 Solesta 48 reactogenicity 48 Catheter ablation 48 unfractionated heparin 48 Drug Eluting Stent 48 Intravascular 48 KYNAPID 48 Ranibizumab 48 QTc 48 ALA PDT 48 Dacogen decitabine 48 Stent thrombosis 48 Plicera 48 MIST II 48 adalimumab 48 IR prednisone 48 pharmacodynamic PD 48 intravenous tPA 48 lumbar spine BMD 48 GORE TAG ® 47 GORE ® 47 ReoPro 47 Interrater reliability 47 carotid IMT 47 severe gastroparesis 47 FASLODEX 47 ONTARGET 47 #mg dose [002] 47 TNF antagonist 47 L PPDS 47 reslizumab 47 embolic protection devices 47 drug eluting coronary stents 47 risperidone Risperdal 47 adjuvant radiotherapy 47 subcutaneous SC 47 combretastatin A4 phosphate CA4P 47 viral kinetics 47 defibrillator CRT D 47 LHRH agonist 47 Crohn Disease Activity 47 milrinone 47 histologically confirmed 47 PROactive study 47 solifenacin 47 Arch Surg 47 APPRAISE 47 direct thrombin inhibitors 47 interobserver reliability 47 darunavir ritonavir 47 decitabine 47 unique alkylating agent 47 ketorolac 47 BioMatrix TM 47 Atrial Flutter 47 FFNS 47 MiDAS 47 rtPA 47 recurrent GBM 47 CABG surgery 47 carotid revascularization 47 transdermal contraceptive 47 Trofex 47 SF #v# 47 Cariprazine 47 infusional 47 radiotherapy RT 47 Long Lesion 47 Appropriateness Criteria 47 Lamotrigine 47 oral treprostinil 47 Rilonacept 47 acute coronary syndromes ACS 47 Unstable Angina 47 interferon beta 1b 47 Erectile function 47 Endarterectomy 47 ACCLAIM 47 Symptom severity 47 NOXAFIL Oral Suspension 47 DOXIL 47 arterial thrombosis 47 Ambulatory EHR ensures 47 Interferon beta 1a 47 hemodynamic measurements 47 biostatistical analysis 47 OLYMPIA registry 47 Central Venous Catheter 47 STARFlex ® 47 Secondary endpoints include 47 immunosuppression therapy 47 prospectively defined 47 Vectibix monotherapy 47 prognostic variables 47 Automated Breast Ultrasound 47 ECASS 47 surgical revascularization 47 drug eluting balloons 47 unicompartmental knee 47 SPIRIT III 47 QTinno 47 endoscopic remission 47 MADIT 47 pegylated liposomal doxorubicin 47 eluting stent 47 adenotonsillectomy 47 Sapien XT 47 differentiate squamous 47 REMICADE ® 47 ADAS cog 47 thromboembolic events 47 antiangiogenic therapy 47 Epirubicin 47 HAQ DI 47 MDRD 47 Spinal Cord Stimulation 47 dosing cohort 47 hip resurfacing arthroplasty 47 receiving SIMPONI 47 EOquin TM 47 secondary efficacy endpoints 47 Dacogen injection 47 REVIVE Diabetes 47 regorafenib 47 Laura Mauri 47 citalopram hydrobromide 47 eptifibatide 47 chemoradiotherapy 47 OPAXIO TM 47 pharmacokinetic parameters 47 preclinical pharmacology 46 erection hardness 46 myocardial reperfusion 46 implanted stent 46 assessing T DM1 46 Polysomnography 46 pump IABP 46 QVAR R 46 Yondelis ® 46 multicenter Phase 46 Schizophrenia Treatment 46 Rating Scale UPDRS 46 R# #mg BID 46 ADAS Cog 46 PIX# [002] 46 INVEGA ® 46 acute ischemic stroke 46 exploratory endpoints 46 Amarenco 46 NATRECOR R 46 underwent CABG 46 BACcel 46 Vascular Stent 46 Sorafenib Nexavar 46 placebo controlled clinical 46 MYLOTARG 46 IBS C 46 retrospectively analyzed 46 epicardial 46 CONCERTA 46 prespecified 46 EuroSCORE 46 Dual Antiplatelet Therapy 46 transcervical 46 MDCT angiography 46 euglycemic clamp 46 Elitek 46 ADMIRE HF 46 ER CHOP 46 QIDS SR 46 hylan GF 46 YMRS 46 prospective longitudinal 46 amalgam fillings mercury vapor 46 debulking surgery 46 rosuvastatin 46 SIMCOR 46 ST Elevation Myocardial 46 tolerability pharmacokinetics 46 Sideguard 46 CYP#A# inhibitor 46 electroencephalographic 46 subcutaneous PRO 46 percutaneous cryoablation 46 depsipeptide 46 ORENCIA R 46 Sandostatin LAR 46 achieved CCyR 46 DLQI 46 FDG PET imaging 46 Anturol TM 46 drug eluting stents 46 Platinol ® cisplatin 46 INVEGA SUSTENNA 46 ratio ICER 46 carotid endarterectomy 46 intraclass correlation coefficients 46 Aggrenox ® 46 neoadjuvant 46 placebo controlled dose escalation 46 prospective observational studies 46 Sirolimus Eluting Coronary Stent 46 INTERCEPT treated 46 Coversyl 46 Augment ™ Bone Graft 46 attain statistical significance 46 contrast induced nephropathy 46 antiretroviral naïve 46 thromboembolic disease 46 ascending dose 46 meta regression 46 LATUDA 46 mesilate 46 label multicenter Phase 46 sorafenib Nexavar 46 Drug eluting stents 46 unexplained syncope 46 Biolimus A9 46 mild hepatic impairment 46 neoadjuvant treatment 46 fulvestrant 46 blinded randomized 46 PRISTIQ 46 unified finite element 46 arthroplasties 46 WOMAC scores 46 receiving VELCADE 46 Recurrent Glioblastoma 46 Arixtra ® 46 CRp 46 KAPVAY TM 46 terminally sterilized 46 PREOS 46 QOPI 46 sunitinib malate 46 romidepsin 46 Neuradiab 46 cryptogenic stroke 46 pharmacodynamic parameters 46 bazedoxifene conjugated estrogens 46 PROTEGE 46 polysomnographic 46 TQT 46 bone marrow reticulin deposition 46 peg interferon 46 overnight polysomnography 46 GnRH agonist 46 FOCALIN XR 46 stenting procedures 46 PREVENT IV 46 stent implantation 46 creatinine clearance CrCl 46 REG1 Anticoagulation System 46 subthreshold depression 46 stent 46 Taxus Liberte 46 Thrombolytic 46 psychosocial variables 45 anticoagulated 45 EORTC QLQ C# 45 treatment naive genotype 45 bivariate analysis 45 actigraphy 45 Montgomery Asberg Depression 45 sevelamer 45 ST elevation myocardial 45 prasugrel Effient 45 cardiopulmonary bypass 45 Angiox R 45 Acute Coronary Syndrome 45 endocrinologic 45 NSABP C 45 Score DAS 45 fludarabine cyclophosphamide 45 interrater reliability 45 See CLINICAL PHARMACOLOGY 45 Main Outcome Measure 45 chlorambucil 45 clinico pathological 45 Implantable Cardioverter Defibrillator ICD 45 HCQ 45 EKC Cide 45 nimodipine 45 Bionate ® PCU 45 COPAXONE 45 Prospective Randomized Trial 45 PITX2 methylation 45 randomized multicenter 45 plain radiographs 45 ARIXTRA R 45 Medtronic stent 45 www.sanbolic.com 45 clopidogrel pretreatment 45 Beu Burkman 8 45 DEFER 45 Apixaban 45 Rating Scale MADRS 45 treated nonsurgically 45 OMAPRO ™ 45 procedural sedation 45 MIRAPEX 45 immunohistochemical 45 AIM HIGH 45 clinicopathological features 45 stent graft 45 ICD CRT 45 samalizumab 45 coronary drug eluting 45 bortezomib refractory 45 Vicor PD2i 45 diagnosing coronary artery 45 ® Integration CMMI 45 NovaSure 45 ziprasidone 45 oral levofloxacin 45 rivaroxaban 45 PREZISTA r 45 CROSSER 45 acyclovir Lauriad R 45 Series HWOL 45 REVLIMID lenalidomide 45 radiographic progression 45 calcaneal fractures 45 bosentan 45 based econazole lacquer 45 REALITY Trial 45 anti restenotic 45 FK# 45 methotrexate therapy 45 Secondary efficacy endpoints 45 genomic biomarker 45 antiangiogenic agent 45 SELENA SLEDAI 45 APEX AMI trial 45 transrectal ultrasound guided 45 tacrolimus ointment 45 mg administered orally 45 onset AF 45 Injury Severity Score 45 trabeculectomy 45 Sanvar R 45 Neles 45 coronary stent 45 ACTOplus met 45 clinicopathological 45 trabectedin 45 IVTA 45 retrospectively reviewed 45 Liberte stent 45 Calmare pain 45 observational cohort 45 Percutaneous Tibial Nerve Stimulation 45 mTOR inhibitor 45 acute coronary syndrome 45 Phase #b/#a trial 45 STEMI 45 VITALITY 45 lipid lowering drugs 45 treatment naïve genotype 45 FRAGMIN R 45 vein ablation 45 via intradermal injections 45 SpideRX 45 Climara 45 stenting 45 thrombotic events 45 nasal symptom 45 Cystic Fibrosis Questionnaire Revised 45 budesonide 44 lamotrigine 44 bifurcation stent 44 unicompartmental 44 Drug Eluting Stents 44 multivariate Cox 44 bivalirudin 44 neoadjuvant chemotherapy 44 Inventory BPI 44 cardiac resynchronization therapy 44 blinded randomized placebo controlled 44 EGRIFTA ™ tesamorelin 44 Taxus Liberté 44 PRoFESS 44 zalutumumab 44 NREMT 44 Vectra DA 44 prospectively randomized 44 Hydroxyurea 44 Scale EDSS 44 Mylotarg 44 tapentadol 44 Adjunctive 44 APTIVUS r 44 DLTs 44 IMPROVE HF 44 eluting stents 44 SUCCEED trial 44 multicentre prospective 44 blinded randomized controlled 44 endovascular aneurysm repair 44 TACE 44 multicentric 44 VATS lobectomy 44 ADONIS 44 PHASE III 44 valvulopathy 44 Resection 44 beta estradiol 44 conditional logistic regression 44 moderate renal impairment 44 Alfimeprase 44 Alzheimer Disease Assessment 44 aplindore 44 DXA scans 44 LUMINATE 44 STEMI undergoing